Drugs / LMG324
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02398500 | Jul 2015 → Feb 2016 | age-related macular degeneration | Alcon Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LMG324 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02398500 ↗ |
| Route | Intravitreal | “single intravitreal (IVT) dose of LMG324” NCT02398500 ↗ |